Phase I study on tolerability of AVN 211 for treatment of Alzheimer's disease
Phase of Trial: Phase I
Latest Information Update: 26 Oct 2009
At a glance
- Drugs AVN 211 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Avineuro Pharmaceuticals
- 18 Nov 2008 New trial record.
- 03 Nov 2008 This trial is expected to be initiated in 2009, according to an Avineuro Pharmaceuticals media release.